🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "focused steps to tackle cost of living pressures" in next month's financial statement.

Speaking to the BBC, she emphasized that reducing price rises is a shared task of both the administration and the central bank.

The UK's price growth is forecast to be the most elevated among the Group of Seven developed nations this year and the following year.

Possible Utility Cost Measures

Sources suggest the government could intervene to reduce utility costs, such as by slashing the current 5% rate of value-added tax applied on energy.

Another approach is to cut some of the policy costs currently included in household expenses.

Budgetary Constraints and Expert Predictions

The government will obtain the latest assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much scope there is for such measures.

The expectation from most economists is that the Chancellor will have to announce higher taxes or spending cuts in order to adhere to her declared debt limits.

Earlier on Thursday, estimates indicated there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the lower end of expectations.

"It is a collective job between the central bank and the government to further reduce some of the sources of inflation," Reeves told the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Tax Commitments and Global Concerns

While much of the attention has been on probable tax rises, the chancellor said the most recent information from the OBR had not changed her vow to election pledges not to raise tax levels on income tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with growing international and trade concerns for the fiscal tax moves, likely to be directed on those "most able to pay."

Global Economic Tensions

Commenting on concerns about the UK's trade ties with the Asian nation she said: "Our security interests invariably take priority."

Last week's declaration by Chinese authorities to increase export controls on rare earths and other resources that are essential for high-technology production led American leader Donald Trump to threaten an extra 100% import tax on goods from the Asian country, raising the possibility of an full-scale trade war between the two global powers.

The US Treasury Secretary called China's action "economic coercion" and "a global supply chain control attempt."

Asked about accepting the American proposal to join its battle with China, Reeves said she was "deeply worried" by Chinese actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "damaging for the global economy and creates further headwinds."

"In my view there are fields where we must address China, but there are also significant chances to trade with China's economy, including banking sector and other areas of the economic system. We've got to get that equilibrium right."

The chancellor also confirmed she was collaborating with G7 counterparts "on our own critical minerals plan, so that we are less reliant."

Health Service Medicine Pricing and Funding

The Chancellor also recognized that the price the NHS spends on pharmaceuticals could rise as a result of current negotiations with the Trump administration and its pharmaceutical firms, in return for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping operations in the United Kingdom, with some attributing the modest returns they are receiving.

Last month, the Science Minister said the price the health service spends on medicines would have to increase to stop companies and drug research funding departing from the UK.

The Chancellor told media: "We have seen due to the cost structure, that medical research, innovative medicines have not been provided in the UK in the way that they are in other EU nations."

"Our aim is to make sure that people getting treatment from the NHS are can access the best essential treatments in the world. And so we are looking at this situation, and... aiming to obtain increased funding into the UK."